Fanconi anaemia - PubMed (original) (raw)
Review
Fanconi anaemia
M D Tischkowitz et al. J Med Genet. 2003 Jan.
Abstract
Fanconi anaemia (FA) is an autosomal recessive disease characterised by congenital abnormalities, defective haemopoiesis, and a high risk of developing acute myeloid leukaemia and certain solid tumours. Chromosomal instability, especially on exposure to alkylating agents, may be shown in affected subjects and is the basis for a diagnostic test. FA can be caused by mutations in at least seven different genes. Interaction pathways have been established, both between the FA proteins and other proteins involved in DNA damage repair, such as ATM, BRCA1 and BRCA2, thereby providing a link with other disorders in which defective DNA damage repair is a feature. This review summarises the clinical features of FA and the natural history of the disease, discusses diagnosis and management, and puts the recent molecular advances into the context of the cellular and clinical FA phenotype.
Similar articles
- Fanconi anaemia and leukaemia - clinical and molecular aspects.
Tischkowitz M, Dokal I. Tischkowitz M, et al. Br J Haematol. 2004 Jul;126(2):176-91. doi: 10.1111/j.1365-2141.2004.05023.x. Br J Haematol. 2004. PMID: 15238138 Review. - Fanconi anemia: current management.
Kook H. Kook H. Hematology. 2005;10 Suppl 1:108-10. doi: 10.1080/10245330512331390096. Hematology. 2005. PMID: 16188650 Review. - The Fanconi anaemia/BRCA pathway.
D'Andrea AD, Grompe M. D'Andrea AD, et al. Nat Rev Cancer. 2003 Jan;3(1):23-34. doi: 10.1038/nrc970. Nat Rev Cancer. 2003. PMID: 12509764 Review. - Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei.
Francies FZ, Wainwright R, Poole J, De Leeneer K, Coene I, Wieme G, Poirel HA, Brichard B, Vermeulen S, Vral A, Slabbert J, Claes K, Baeyens A. Francies FZ, et al. DNA Repair (Amst). 2018 Jan;61:17-24. doi: 10.1016/j.dnarep.2017.11.001. Epub 2017 Nov 8. DNA Repair (Amst). 2018. PMID: 29154021 - [From gene to disease: Fanconi anemia].
Zwaan CM, Joenje H. Zwaan CM, et al. Ned Tijdschr Geneeskd. 2003 Feb 22;147(8):342-4. Ned Tijdschr Geneeskd. 2003. PMID: 12661120 Review. Dutch.
Cited by
- Management of dental extraction in a female patient with fanconi anemia.
Peisker A, Raschke GF, Guentsch A, Roshanghias K, Schultze-Mosgau S. Peisker A, et al. J Dent (Tehran). 2014 Sep;11(5):613-9. Epub 2014 Sep 30. J Dent (Tehran). 2014. PMID: 25628690 Free PMC article. - Functional interaction of BRCA1/ATM-associated BAAT1 with the DNA-PK catalytic subunit.
So EY, Ouchi T. So EY, et al. Exp Ther Med. 2011 May;2(3):443-447. doi: 10.3892/etm.2011.232. Epub 2011 Mar 21. Exp Ther Med. 2011. PMID: 22977523 Free PMC article. - The Fanconi anemia pathway controls oncogenic response in hematopoietic stem and progenitor cells by regulating PRMT5-mediated p53 arginine methylation.
Du W, Amarachintha S, Erden O, Wilson A, Pang Q. Du W, et al. Oncotarget. 2016 Sep 13;7(37):60005-60020. doi: 10.18632/oncotarget.11088. Oncotarget. 2016. PMID: 27507053 Free PMC article. - Overexpression of IL-3Rα on CD34+CD38- stem cells defines leukemia-initiating cells in Fanconi anemia AML.
Du W, Li XE, Sipple J, Pang Q. Du W, et al. Blood. 2011 Apr 21;117(16):4243-52. doi: 10.1182/blood-2010-09-309179. Epub 2011 Feb 17. Blood. 2011. PMID: 21330473 Free PMC article. - Integrating Gene Correction in the Reprogramming and Transdifferentiation Processes: A One-Step Strategy to Overcome Stem Cell-Based Gene Therapy Limitations.
Lee SY, Chung SK. Lee SY, et al. Stem Cells Int. 2016;2016:2725670. doi: 10.1155/2016/2725670. Epub 2016 Dec 15. Stem Cells Int. 2016. PMID: 28074097 Free PMC article. Review.
References
- Cytogenet Cell Genet. 2001;93(3-4):203-6 - PubMed
- Hum Mol Genet. 2002 Feb 1;11(3):273-81 - PubMed
- Hum Mol Genet. 2002 Feb 15;11(4):439-44 - PubMed
- Proc Natl Acad Sci U S A. 2001 May 8;98(10):5734-9 - PubMed
- Br J Haematol. 1991 Mar;77(3):410-8 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous